Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1

Medical University of South Carolina1,122 enrolled

Overview

The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion). The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

1,122

Conditions

Smoking Cessation

Interventions

Enhanced CareBEHAVIORAL

Smokers in the enhanced care group will receive live counseling (either in person or telehealth consult) while hospitalized combined with post-hospital discharge automated calls using interactive voice recognition (IVR) technology.

Basic CareBEHAVIORAL

Smokers assigned to the basic care group will only receive the post-discharge IVR phone calls.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18+ years and older * hospitalized cigarette smokers eligible for either enhanced or basic care * discharged from the hospital back to their home Exclusion Criteria: * patients without a phone number * those unable to communicate in the English language

Locations (6)

Institute of Psychiatry

Charleston, South Carolina, United States

MUSC

Charleston, South Carolina, United States

MUSC

Chester, South Carolina, United States

MUSC

Florence, South Carolina, United States

Outcomes

Primary Outcomes

Self-reported smoking prevalence 6-weeks after hospitalization.

Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2-fold higher 7-day non-smoker prevalence rate after hospitalization (i.e., 20% vs 10%)

Time frame: Assessed 6-weeks post-discharge

Self-reported use of FDA Approved Smoking Cessation Medication

Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2.5-fold greater use of an FDA approved stop smoking medication after hospitalization (i.e., 20% vs 8%)

Time frame: Assessed 6-weeks post-discharge

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.